Immune Guard Synbiotics (30 Capsules)

AGIMMUG15B30-HK

  • Support Immunity
  • Post-Illness Recovery
  • Illness Prevention
HK$219.00 HKD
HK$219.00 HKD HK$399.00 HKD
Shipping calculated at checkout.
  • Gut Health
  • Vegetarian
  • Capsule
  • Fast & Secure Checkout
  • Trusted by Customers
  • Highly Rated & Recommended

Product Features

Dual ImmuneGuard Formula featuring postbiotic EpiCor® and probiotic Bifidobacterium lactis BI‑04®
Clinically supported to help reduce common illness symptoms, including muscle aches, cough, fatigue, headache, and sore throat

Ingredients

EpiCor® dried yeast fermentate Saccharomyces cerevisiae, bulking agent (Algalithe P® (Lithothamnion calcareum and pregelatinized corn starch)), white vegetarian capsule (hypromellose, colour (titanium dioxide)), fructo-oligosaccharides, anticaking agent (magnesium stearate, silicon dioxide), Bifidobacterium lactis Bl-04, Vitamin D3.

Directions

Children 6 years and above and adults, take 2 capsules daily, with a meal.
For children, open the capsules and consume.

Country of Origin

USA

Cautions

For use during an antibiotic treatment; take at least 2-3 hours before or after antibiotics. Consult a healthcare practitioner prior to use if you are under a medical condition. Individuals with allergies to any of the ingredients should not use this product. Keep out of reach of children. Store in a cool dry place below 25°C. This product is made from natural sources and may have color variation. This is a normal phenomenon and does not affect product quality.
Immune Guard Synbiotics (30 Capsules)

HK$219.00 HKD

營養參數

Servings Per Package / 每包裝所含食用分量數目: 15
Serving Size / 食用分量: 2
Per Serving/每食用分量
Energy 0.54kcal
Protein 0.0g
Total Fat 0.02g
Saturated Fat 0.02g
Trans Fat 0g
Total Carbohydrates 0.16g
Dietary Fiber 0.14g
Sugars 0.02g
Sodium 0.02mg
Vitamin D3 2.50μg

ᵃWiertsema, S. P. et al. (2021). Nutrients, 13(3), 886.
¹Jensen, G. S. et al. (2011). J Med Food, 14(9):1002-10.
²Jensen, G. S. et al. (2007). Nutrition research (New York, N.Y.), 27(6), 327–335.
³Singh, R.G. et al. (2024). Pediatr Res 96, 1739–1748
⁴Danisco. (2020).Technical Memorandum. TM 46-le